US 8143218
Treatment of skin, and wound repair, with thymosin beta 4
granted A61KA61K38/08A61K38/1841
Quick answer
US patent 8143218 (Treatment of skin, and wound repair, with thymosin beta 4) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERX BIOPHARMACEUTICALS, INC.
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/08, A61K38/1841, A61K38/2292, A61K45/06